Epidemiological Study on the Prevalence of Mental Disorders in Slovakia
NCT ID: NCT07129408
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
3100 participants
OBSERVATIONAL
2025-02-13
2025-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The proposed project will provide unique data that have not yet been available in Slovakia on the prevalence of the most common mental disorders in the adult population in relation to age, gender, level of education, and broader social and economic contexts. It will also offer insights into the relationship between risk factors and the onset and course of these mental disorders, their overall societal impact, and the use or absence of mental health care services.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014
The Prevalence of Insomnia in Patients With Psychiatric Disorders
NCT05408013
Epidemiology of Schizophrenia in Bulgaria
NCT00984373
Somatic Comorbidities in Psychiatric Patients
NCT02773108
Influence of Environmental Factors and Schizophrenia
NCT03296384
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This survey on the prevalence of mental disorders and their associated risk factors will be conducted as a cross-sectional study using the internationally recognized and standardized Mini International Neuropsychiatric Interview (MINI).
The MINI instrument will be administered first to 100 respondents in a pilot phase and then to a representative sample of 3,000 respondents. Participants will be selected using a multistage sampling method that covers the entire adult population of the Slovak Republic. The selection process and data collection will be conducted by a professional research agency.
The sample size has been carefully calculated to ensure that the results are generalizable to the entire adult population of Slovakia, with a 95% confidence interval and a 2% margin of error. This representative sample will make it possible to gather sufficient data even on the least common mental disorders (with a prevalence of around 1%), ensuring that the findings are both meaningful and statistically robust.
Data collection will take place through face-to-face interviews conducted by trained interviewers from the research agency, all of whom will receive specialized training in administering the MINI tool. The data will then be subject to in-depth analysis and interpretation by experts in epidemiology, clinical psychology, sociology, and psychiatry. This multidisciplinary evaluation will serve as the foundation for developing recommendations for key ministries - including those responsible for health, education, family, and social affairs - as well as for other sectors of society. The results will also be internationally comparable, as they will align with data collected using the same methodology in other countries.
The analysis of the collected data will help identify unmet needs in mental health care, support improvements in the care of individuals with mental disorders, guide the development of a comprehensive care network, highlight at-risk population groups, and inform targeted prevention strategies.
Ultimately, this study will generate unique data - previously unavailable in Slovakia - on the prevalence of the most common mental disorders in the adult population, with regard to age, gender, educational level, and broader social and economic factors. It will also provide valuable insights into the relationship between risk factors and the development and course of mental disorders, their overall impact on society, and the accessibility and utilisation of mental health care services.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability and willingness to undergo a face-to-face interview with an interviewer, to answer interviewer's questions from a questionnaire
* signing an informed consent
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Union
OTHER
European Commission
OTHER
Comenius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexandra Brazinova
Chair of Institute of Epidemiology, Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Brazinova, prof. MD PhD
Role: PRINCIPAL_INVESTIGATOR
Comenius University, Faculty of Medicine, Institute of Epidemiology
Michal Hajduk, assoc.prof. PhD
Role: STUDY_CHAIR
Comenius University, Faculty of Arts, Department of Psychology
Maria Kralova, assoc.prof. MD PhD
Role: STUDY_CHAIR
Comenius University, Faculty of Medicine, Department of Psychiatry
Marek Majdan, prof. MS PhD
Role: STUDY_CHAIR
Trnava University, Faculty of Health Care and Social Work
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ministry of Health of the Slovak Republic
Bratislava, , Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of Ministry of Health of the Slovak Republic, informing about the study in Slovak language
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Z091007-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.